Pipeline - Clindamycin Product Profile13 Apr 2021
Clindamycin 150mg/ml Solution for Injection (2ml & 4ml Amp) Dalacin® / Pfizer
Antibacterial. Serious infections caused by susceptible Gram-positive organisms,
staphylococci (both penicillinase- and non-penicillinase-producing),
streptococci (except Streptococcus faecalis) and pneumococci.
It is also indicated in serious infections caused by susceptible anaerobic pathogens such as Bacteroides spp, Fusobacterium spp, Propionibacterium spp, Peptostreptococcus spp. and microaerophilic streptococci.
Clindamycin does not penetrate the blood/brain barrier in therapeutically effective quantities.
Dossier Status: On-going / EU CTD Available: 2022
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Two (2) years
Batch Sizes: To be defined
Pack Sizes: To be defined
Originator pack: Box x 1, 5 & 10 Ampoules.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation